Ultrasound-Guided Stellate Ganglion Block: A Promising Option for PTSD and Trauma Recovery

For decades, treating post-traumatic stress disorder (PTSD) has meant a slow climb through talk therapy and medications — often effective, but rarely fast. In the last several years, a procedure borrowed from pain medicine has drawn growing attention as a rapid- acting option: the stellate ganglion block (SGB). Performed under ultrasound guidance, this outpatient injection is being explored not just for combat-related PTSD, but for the aftermath of breakups, grief, assault, accidents, and other forms of acute psychological trauma.

This post walks through what SGB is, how it’s thought to work, what the evidence actually shows, and who might be a candidate.

What Is a Stellate Ganglion Block?

The stellate ganglion is a cluster of sympathetic nerves located in the neck, near the base of the cervical spine. It’s a key relay station in the body’s “fight-or-flight” system. In an SGB, a physician injects a local anesthetic — typically bupivacaine or ropivacaine — directly next to this ganglion, temporarily quieting the sympathetic nerve signals that travel up to the head, neck, and upper limbs.

SGB has been used safely for decades to treat conditions like complex regional pain syndrome, phantom limb pain, and certain cardiac arrhythmias. Its use for psychiatric symptoms is newer, but the underlying idea is straightforward: PTSD is associated with a chronically overactive sympathetic nervous system, and dialing that down may ease the biological drivers of hyperarousal, intrusive memories, and anxiety.

Why Ultrasound Guidance Matters

Older versions of this procedure relied on anatomical landmarks or fluoroscopy (X-ray guidance). Ultrasound guidance has become the preferred approach because it lets the physician visualize the carotid artery, jugular vein, thyroid, esophagus, and nerve roots in real time, steering the needle away from them. This significantly lowers the risk of the procedure’s most common complications, such as inadvertent vascular injection or nerve injury, and allows for a more precise, lower-volume injection. The procedure itself typically takes 15–30 minutes, is done with the patient awake, and requires only local numbing at the injection site.

The Evidence for PTSD

This is where nuance matters. SGB is not FDA-approved specifically for PTSD, and it’s administered off-label, usually by anesthesiologists or pain specialists.

The research picture is genuinely mixed but improving:

• Multiple case series and retrospective cohort studies — including a large multisite retrospective analysis — have reported significant reductions in PTSD symptom scores after SGB, across both military and civilian populations, with effects sometimes lasting six months or longer.
• However, of the two published randomized controlled trials (the gold standard for evidence), one showed a positive effect and one was negative, with researchers citing methodological limitations in both. A larger, more definitive VA-funded multisite trial is now underway specifically to resolve this uncertainty.
• A 2025 systematic review and meta-analysis concluded that there is some evidence SGB can help ease PTSD symptoms, and that it may also help with commonly co-occurring anxiety and depression, but called for more consistent, higher-quality studies to nail down optimal technique, dosing, and follow-up protocols.
• Bilateral (both-sides) blocks, sometimes combined with a superior cervical ganglion block, have been studied as an option for patients who don’t respond to a single right- sided injection, with a good safety profile, though not necessarily better long-term results.

In short: the biological rationale is plausible and imaging studies support a link between the stellate ganglion and the brain circuits involved in threat processing, and real-world clinical experience has been encouraging for many patients — but SGB should currently be considered an emerging, adjunctive treatment rather than a proven, first-line cure.

Reported Benefits

Patients and clinicians who use SGB for trauma-related symptoms describe several potential benefits:

• Rapid onset. Unlike SSRIs or trauma-focused psychotherapy, which can take weeks to months to show benefit, some patients report a reduction in hyperarousal, sleep disturbance, and anxiety within days.
• Low systemic burden. Because the injection is localized, it avoids the side-effect profile of daily psychiatric medications (weight change, sexual side effects, emotional blunting).
• Complementary, not competitive. SGB is increasingly studied as an add-on that may make patients more receptive to trauma-focused therapy (like EMDR or prolonged exposure) rather than a replacement for it.
• Repeatable. The block can be redone if benefits fade, and many protocols involve a second injection a few weeks after the first.
• Minimal downtime. It’s an outpatient procedure with a short recovery window — most people go home the same day with instructions to avoid strenuous activity for 24 hours.

Beyond Combat PTSD: Breakups and Other Trauma

Much of the formal research on SGB has focused on veterans, since military PTSD programs have driven most of the funding and case volume. But the underlying mechanism — a sympathetic nervous system stuck in overdrive — isn’t unique to combat trauma. Some pain and psychiatric clinics now offer SGB for civilians experiencing acute grief, the emotional aftermath of a breakup, assault, sudden loss, or accidents, framing it as a way to “unstick” the nervous system’s stress response.

It’s worth being direct here: there is far less peer-reviewed evidence for these non-combat, non-PTSD applications specifically. Much of what’s used to justify this broader use is inference from the PTSD literature, case reports, and clinical experience rather than dedicated trials. That doesn’t mean it’s without merit, but anyone considering SGB for a breakup or a single stressful event should understand they’re in less-studied territory than someone with a formal PTSD diagnosis.

Who Might Be a Candidate

SGB is generally considered for people who:

• Have a diagnosed anxiety or trauma-related condition, particularly PTSD, that hasn’t responded adequately to first-line treatments
• Are looking for a bridge to make psychotherapy more tolerable or effective
• Have no contraindications, such as bleeding disorders, certain heart rhythm conditions, or local infection at the injection site
• Are working with a qualified anesthesiologist or interventional pain physician experienced in the technique

Risks and Limitations

SGB is generally well-tolerated, but it isn’t risk-free. Temporary side effects can include a droopy eyelid, hoarse voice, or a warm, flushed feeling on one side of the face (all related to the nearby nerves being temporarily affected — a sign the block is working, known as Horner’s syndrome). Rare but more serious risks include inadvertent injection into a blood vessel, seizure from local anesthetic toxicity, or pneumothorax. Ultrasound guidance has substantially reduced these risks compared to older techniques.

The Bottom Line

Ultrasound-guided stellate ganglion block is a genuinely interesting, biologically plausible, and increasingly studied option for PTSD, with a growing (if still imperfect) evidence base and a good safety profile when performed by an experienced provider. Its use for civilian trauma like breakups or grief is more speculative and rests on thinner evidence. Anyone considering it should talk with a psychiatrist or trauma-informed clinician about how it fits alongside — not instead of — evidence-based therapies, and should seek out a provider with specific experience performing SGB for psychiatric indications.

This article is for informational purposes only and is not a substitute for professional medical advice. If you’re struggling with PTSD or the aftermath of a traumatic event, please consult a licensed mental health or medical professional to discuss whether SGB or other treatments are appropriate for you.